Comments
Loading...

Ocugen Analyst Ratings

OCGNNASDAQ
Logo brought to you by Benzinga Data
$0.9579
0.032.91%
At close: -
$0.9512
-0.00670-0.70%
After Hours: 7:59 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$8.00
Lowest Price Target1
$2.00
Consensus Price Target1
$5.17

Ocugen Analyst Ratings and Price Targets | NASDAQ:OCGN | Benzinga

Ocugen Inc has a consensus price target of $5.17 based on the ratings of 6 analysts. The high is $8 issued by Roth Capital on June 15, 2022. The low is $2 issued by Cantor Fitzgerald on August 31, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Chardan Capital, and Chardan Capital on May 12, 2025, May 12, 2025, and March 6, 2025, respectively. With an average price target of $7 between HC Wainwright & Co., Chardan Capital, and Chardan Capital, there's an implied 635.91% upside for Ocugen Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Jan
2
Feb
2
Mar
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Chardan Capital
Maxim Group
Cantor Fitzgerald
Mizuho

1calculated from analyst ratings

Analyst Ratings for Ocugen

Buy NowGet Alert
05/12/2025Buy Now635.91%HC Wainwright & Co.
Swayampakula Ramakanth51%
$8 → $7MaintainsBuyGet Alert
05/12/2025Buy Now635.91%Chardan Capital
Daniil Gataulin43%
$7 → $7MaintainsBuyGet Alert
03/06/2025Buy Now635.91%Chardan Capital
Daniil Gataulin43%
$6 → $7MaintainsBuyGet Alert
03/06/2025Buy Now741.04%HC Wainwright & Co.
Swayampakula Ramakanth51%
$8 → $8ReiteratesBuy → BuyGet Alert
02/13/2025Buy Now530.78%Chardan Capital
Daniil Gataulin43%
$6 → $6MaintainsBuyGet Alert
02/13/2025Buy Now741.04%HC Wainwright & Co.
Swayampakula Ramakanth51%
$7 → $8MaintainsBuyGet Alert
01/23/2025Buy Now530.78%Chardan Capital
Daniil Gataulin43%
$6 → $6MaintainsBuyGet Alert
01/13/2025Buy Now635.91%HC Wainwright & Co.
Swayampakula Ramakanth51%
$7 → $7ReiteratesBuy → BuyGet Alert
11/18/2024Buy Now530.78%Chardan Capital
Daniil Gataulin43%
$6 → $6MaintainsBuyGet Alert
11/14/2024Buy Now635.91%HC Wainwright & Co.
Swayampakula Ramakanth51%
$7 → $7ReiteratesBuy → BuyGet Alert
11/11/2024Buy Now635.91%HC Wainwright & Co.
Swayampakula Ramakanth51%
$7 → $7ReiteratesBuy → BuyGet Alert
11/08/2024Buy Now530.78%Chardan Capital
Daniil Gataulin43%
$6 → $6MaintainsBuyGet Alert
10/23/2024Buy Now635.91%HC Wainwright & Co.
Swayampakula Ramakanth51%
$7 → $7ReiteratesBuy → BuyGet Alert
10/15/2024Buy Now320.52%Maxim Group
Michael Okunewitch29%
→ $4Initiates → BuyGet Alert
05/15/2024Buy Now635.91%HC Wainwright & Co.
Swayampakula Ramakanth51%
$7 → $7ReiteratesBuy → BuyGet Alert
05/15/2024Buy Now425.65%Chardan Capital
Daniil Gataulin43%
$5 → $5MaintainsBuyGet Alert
04/22/2024Buy Now425.65%Chardan Capital
Daniil Gataulin43%
$4 → $5MaintainsBuyGet Alert
04/03/2024Buy Now635.91%HC Wainwright & Co.
Swayampakula Ramakanth51%
→ $7ReiteratesBuy → BuyGet Alert
02/22/2024Buy Now635.91%HC Wainwright & Co.
Swayampakula Ramakanth51%
$7 → $7ReiteratesBuy → BuyGet Alert
01/24/2024Buy Now635.91%HC Wainwright & Co.
Swayampakula Ramakanth51%
$5 → $7MaintainsBuyGet Alert
08/31/2023Buy Now110.26%Cantor Fitzgerald
Jennifer Kim50%
$2.5 → $2MaintainsOverweightGet Alert
08/23/2023Buy Now425.65%HC Wainwright & Co.
Swayampakula Ramakanth51%
→ $5ReiteratesBuy → BuyGet Alert
05/08/2023Buy Now320.52%Chardan Capital
Daniil Gataulin43%
$3.5 → $4MaintainsBuyGet Alert
04/17/2023Buy Now425.65%HC Wainwright & Co.
Swayampakula Ramakanth51%
→ $5Reiterates → BuyGet Alert
04/14/2023Buy Now267.96%Chardan Capital
Daniil Gataulin43%
→ $3.5MaintainsBuyGet Alert
03/01/2023Buy Now267.96%Chardan Capital
Daniil Gataulin43%
→ $3.5UpgradeNeutral → BuyGet Alert
03/01/2023Buy Now215.39%Mizuho
Uy Ear62%
$5 → $3MaintainsBuyGet Alert
03/01/2023Buy Now425.65%HC Wainwright & Co.
Swayampakula Ramakanth51%
$6 → $5Reiterates → BuyGet Alert
08/23/2022Buy Now425.65%Mizuho
Uy Ear62%
→ $5Initiates → BuyGet Alert
08/15/2022Buy Now530.78%HC Wainwright & Co.
Swayampakula Ramakanth51%
$7 → $6MaintainsBuyGet Alert
06/15/2022Buy Now741.04%Roth Capital
Jonathan Aschoff34%
→ $8Reinstates → BuyGet Alert
06/02/2022Buy Now373.09%Cantor Fitzgerald
Jennifer Kim50%
→ $4.5Initiates → OverweightGet Alert

FAQ

Q

What is the target price for Ocugen (OCGN) stock?

A

The latest price target for Ocugen (NASDAQ:OCGN) was reported by HC Wainwright & Co. on May 12, 2025. The analyst firm set a price target for $7.00 expecting OCGN to rise to within 12 months (a possible 635.91% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Ocugen (OCGN)?

A

The latest analyst rating for Ocugen (NASDAQ:OCGN) was provided by HC Wainwright & Co., and Ocugen maintained their buy rating.

Q

When was the last upgrade for Ocugen (OCGN)?

A

The last upgrade for Ocugen Inc happened on March 1, 2023 when Chardan Capital raised their price target to $3.5. Chardan Capital previously had a neutral for Ocugen Inc.

Q

When was the last downgrade for Ocugen (OCGN)?

A

There is no last downgrade for Ocugen.

Q

When is the next analyst rating going to be posted or updated for Ocugen (OCGN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocugen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocugen was filed on May 12, 2025 so you should expect the next rating to be made available sometime around May 12, 2026.

Q

Is the Analyst Rating Ocugen (OCGN) correct?

A

While ratings are subjective and will change, the latest Ocugen (OCGN) rating was a maintained with a price target of $8.00 to $7.00. The current price Ocugen (OCGN) is trading at is $0.95, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch